APA

Khurana S., Wu J., Verma N., Verma S., Raghunandan R., Manischewitz J., King L. R., Kpamegan E., Pincus S., Smith G., Glenn G. & Golding H. (20111121). H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans. : Journal of virology.

Chicago

Khurana Surender, Wu Jian, Verma Nitin, Verma Swati, Raghunandan Ramadevi, Manischewitz Jody, King Lisa R, Kpamegan Eloi, Pincus Steven, Smith Gale, Glenn Gregory and Golding Hana. 20111121. H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans. : Journal of virology.

Harvard

Khurana S., Wu J., Verma N., Verma S., Raghunandan R., Manischewitz J., King L. R., Kpamegan E., Pincus S., Smith G., Glenn G. and Golding H. (20111121). H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans. : Journal of virology.

MLA

Khurana Surender, Wu Jian, Verma Nitin, Verma Swati, Raghunandan Ramadevi, Manischewitz Jody, King Lisa R, Kpamegan Eloi, Pincus Steven, Smith Gale, Glenn Gregory and Golding Hana. H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans. : Journal of virology. 20111121.